270 related articles for article (PubMed ID: 16123921)
1. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.
Oldenburg A; Hohmann J; Foert E; Skrok J; Hoffmann CW; Frericks B; Wolf KJ; Albrecht T
Ultraschall Med; 2005 Aug; 26(4):277-84. PubMed ID: 16123921
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
3. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
Oldenburg A; Albrecht T
Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterisation of liver metastases.
Albrecht T; Hohmann J; Oldenburg A; Skrok J; Wolf KJ
Eur Radiol; 2004 Oct; 14 Suppl 8():P25-33. PubMed ID: 15700330
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasonography in diagnosing liver metastases.
Janica JR; Lebkowska U; Ustymowicz A; Augustynowicz A; Kamocki Z; Werel D; Polaków J; Kedra B; Pepinski W
Med Sci Monit; 2007 May; 13 Suppl 1():111-5. PubMed ID: 17507895
[TBL] [Abstract][Full Text] [Related]
6. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases.
Albrecht T; Hoffmann CW; Schmitz SA; Schettler S; Overberg A; Germer CT; Wolf KJ
AJR Am J Roentgenol; 2001 May; 176(5):1191-8. PubMed ID: 11312180
[TBL] [Abstract][Full Text] [Related]
7. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?
Dai Y; Chen MH; Yin SS; Yan K; Fan ZH; Wu W; Wang YB; Yang W
Invest Radiol; 2007 Aug; 42(8):596-603. PubMed ID: 17620943
[TBL] [Abstract][Full Text] [Related]
8. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI.
Dietrich CF; Kratzer W; Strobe D; Danse E; Fessl R; Bunk A; Vossas U; Hauenstein K; Koch W; Blank W; Oudkerk M; Hahn D; Greis C
World J Gastroenterol; 2006 Mar; 12(11):1699-705. PubMed ID: 16586537
[TBL] [Abstract][Full Text] [Related]
9. Screening for liver metastases in women with mammary carcinoma: comparison of contrast-enhanced ultrasound and magnetic resonance imaging.
Hänle MM; Thiel R; Saur G; Mason RA; Pauls S; Kratzer W
Clin Imaging; 2011; 35(5):366-70. PubMed ID: 21872126
[TBL] [Abstract][Full Text] [Related]
10. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
[TBL] [Abstract][Full Text] [Related]
11. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study.
Albrecht T; Blomley MJ; Burns PN; Wilson S; Harvey CJ; Leen E; Claudon M; Calliada F; Correas JM; LaFortune M; Campani R; Hoffmann CW; Cosgrove DO; LeFevre F
Radiology; 2003 May; 227(2):361-70. PubMed ID: 12649417
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing.
Bleuzen A; Huang C; Olar M; Tchuenbou J; Tranquart F
Ultraschall Med; 2006 Feb; 27(1):40-8. PubMed ID: 16470478
[TBL] [Abstract][Full Text] [Related]
13. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
Dörffel Y; Wermke W
Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
[TBL] [Abstract][Full Text] [Related]
16. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI.
Trillaud H; Bruel JM; Valette PJ; Vilgrain V; Schmutz G; Oyen R; Jakubowski W; Danes J; Valek V; Greis C
World J Gastroenterol; 2009 Aug; 15(30):3748-56. PubMed ID: 19673015
[TBL] [Abstract][Full Text] [Related]
17. High mechanical index post-contrast ultrasonography improves tissue structural display of hepatocellular carcinoma.
Chen MH; Yang W; Dai Y; Wu W
Chin Med J (Engl); 2005 Dec; 118(24):2046-51. PubMed ID: 16438901
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.
Konopke R; Kersting S; Bergert H; Bloomenthal A; Gastmeier J; Saeger HD; Bunk A
Int J Colorectal Dis; 2007 Feb; 22(2):201-7. PubMed ID: 16733650
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
[TBL] [Abstract][Full Text] [Related]
20. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ
J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
